Drug
Tiotropium Bromide And Olodaterol
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Chronic Obstructive Pulmonary Disease | 201 | 16.3 | 16.9 | signal |
| 2 | Emphysema | 26 | 10.8 | 10.9 | signal |
| 3 | Productive Cough | 99 | 8.8 | 9.0 | signal |
| 4 | Respiratory Tract Congestion | 32 | 8.5 | 8.5 | signal |
| 5 | Acute Respiratory Failure | 37 | 8.1 | 8.2 | signal |
| 6 | Dyspnoea Exertional | 72 | 8.1 | 8.2 | signal |
| 7 | Candida Infection | 30 | 7.6 | 7.6 | signal |
| 8 | Dry Throat | 18 | 7.5 | 7.5 | signal |
| 9 | Choking | 34 | 7.4 | 7.4 | signal |
| 10 | Oral Discomfort | 23 | 7.0 | 7.0 | signal |
| 11 | Oxygen Saturation Decreased | 91 | 6.9 | 7.0 | signal |
| 12 | Dyspnoea | 910 | 6.8 | 8.1 | signal |
| 13 | Pulmonary Congestion | 21 | 6.7 | 6.7 | signal |
| 14 | Seasonal Allergy | 22 | 6.6 | 6.6 | signal |
| 15 | Dysphonia | 88 | 6.3 | 6.4 | signal |
| 16 | Aphonia | 21 | 6.3 | 6.4 | signal |
| 17 | Throat Irritation | 65 | 6.1 | 6.2 | signal |
| 18 | Cough | 405 | 6.1 | 6.5 | signal |
| 19 | Hospice Care | 14 | 6.0 | 6.0 | signal |
| 20 | Laryngitis | 15 | 5.8 | 5.8 | signal |
| 21 | Secretion Discharge | 17 | 5.8 | 5.8 | signal |
| 22 | Pulmonary Mass | 20 | 5.7 | 5.7 | signal |
| 23 | Device Delivery System Issue | 35 | 5.6 | 5.7 | signal |
| 24 | Extra Dose Administered | 51 | 5.4 | 5.4 | signal |
| 25 | Product Quality Issue | 170 | 5.3 | 5.5 | signal |
| 26 | Lung Neoplasm Malignant | 50 | 5.1 | 5.1 | signal |
| 27 | Retching | 25 | 4.9 | 5.0 | signal |
| 28 | Macular Degeneration | 14 | 4.9 | 5.0 | signal |
| 29 | Wheezing | 68 | 4.8 | 4.9 | signal |
| 30 | Heart Rate Irregular | 26 | 4.8 | 4.8 | signal |
| 31 | Pneumothorax | 17 | 4.5 | 4.5 | signal |
| 32 | Infusion Site Pain | 13 | 4.3 | 4.3 | signal |
| 33 | Product Packaging Quantity Issue | 11 | 4.2 | 4.2 | signal |
| 34 | Respiratory Tract Infection | 26 | 4.2 | 4.2 | signal |
| 35 | Device Malfunction | 66 | 4.1 | 4.2 | signal |
| 36 | Oropharyngeal Pain | 90 | 4.1 | 4.1 | signal |
| 37 | Sputum Discoloured | 9 | 4.0 | 4.0 | signal |
| 38 | Bronchitis | 70 | 4.0 | 4.0 | signal |
| 39 | Dizziness Postural | 9 | 3.9 | 3.9 | signal |
| 40 | Rhinorrhoea | 60 | 3.9 | 4.0 | signal |
| 41 | Sinus Disorder | 18 | 3.8 | 3.8 | signal |
| 42 | Musculoskeletal Chest Pain | 14 | 3.8 | 3.8 | signal |
| 43 | Lung Disorder | 43 | 3.7 | 3.7 | signal |
| 44 | Insurance Issue | 13 | 3.7 | 3.7 | signal |
| 45 | Product Packaging Issue | 8 | 3.6 | 3.6 | signal |
| 46 | Hypoacusis | 37 | 3.6 | 3.6 | signal |
| 47 | Chest Discomfort | 86 | 3.5 | 3.6 | signal |
| 48 | Dry Mouth | 68 | 3.5 | 3.6 | signal |
| 49 | Bronchospasm | 12 | 3.5 | 3.5 | signal |
| 50 | Nasal Congestion | 49 | 3.5 | 3.5 | signal |
| 51 | Ocular Discomfort | 9 | 3.5 | 3.5 | signal |
| 52 | Product Dispensing Error | 17 | 3.3 | 3.3 | signal |
| 53 | Intentional Dose Omission | 21 | 3.2 | 3.2 | signal |
| 54 | Urinary Retention | 25 | 3.2 | 3.2 | signal |
| 55 | Back Disorder | 12 | 3.1 | 3.1 | signal |
| 56 | Feeling Jittery | 14 | 3.1 | 3.1 | signal |
| 57 | Pulmonary Hypertension | 15 | 3.0 | 3.0 | signal |
| 58 | Ear Infection | 19 | 3.0 | 3.0 | signal |
| 59 | Oral Pain | 16 | 3.0 | 3.0 | signal |
| 60 | Dysuria | 26 | 3.0 | 3.0 | signal |
| 61 | Upper Respiratory Tract Infection | 32 | 2.9 | 2.9 | signal |
| 62 | Rib Fracture | 14 | 2.9 | 2.9 | signal |
| 63 | Pulmonary Fibrosis | 13 | 2.9 | 2.9 | signal |
| 64 | Device Issue | 58 | 2.8 | 2.8 | signal |
| 65 | Device Failure | 10 | 2.8 | 2.8 | signal |
| 66 | Hip Fracture | 21 | 2.8 | 2.8 | signal |
| 67 | Taste Disorder | 13 | 2.7 | 2.7 | signal |
| 68 | Skin Laceration | 7 | 2.7 | 2.7 | signal |
| 69 | Haemoptysis | 18 | 2.7 | 2.7 | signal |
| 70 | Pneumonia | 208 | 2.7 | 2.8 | signal |
| 71 | Urinary Incontinence | 19 | 2.7 | 2.7 | signal |
| 72 | Cataract | 38 | 2.7 | 2.7 | signal |
| 73 | Nervousness | 33 | 2.6 | 2.7 | signal |
| 74 | Impaired Quality Of Life | 9 | 2.6 | 2.6 | signal |
| 75 | Eye Infection | 7 | 2.6 | 2.6 | signal |
| 76 | Post Procedural Complication | 12 | 2.6 | 2.6 | signal |
| 77 | Neoplasm | 7 | 2.6 | 2.6 | signal |
| 78 | Feeding Disorder | 12 | 2.5 | 2.5 | signal |
| 79 | Pollakiuria | 25 | 2.5 | 2.5 | signal |
| 80 | Respiratory Disorder | 18 | 2.5 | 2.5 | signal |
| 81 | Hypoaesthesia Oral | 9 | 2.5 | 2.5 | signal |
| 82 | Sinus Congestion | 8 | 2.5 | 2.5 | signal |
| 83 | Tooth Abscess | 6 | 2.5 | 2.5 | no signal |
| 84 | Musculoskeletal Discomfort | 10 | 2.4 | 2.4 | signal |
| 85 | Foot Fracture | 11 | 2.4 | 2.4 | signal |
| 86 | Illness | 58 | 2.4 | 2.4 | signal |
| 87 | Heart Rate Increased | 57 | 2.4 | 2.4 | signal |
| 88 | Atrial Fibrillation | 56 | 2.4 | 2.4 | signal |
| 89 | Hereditary Angioedema | 6 | 2.4 | 2.4 | no signal |
| 90 | Glaucoma | 11 | 2.4 | 2.4 | signal |
| 91 | Intentional Product Use Issue | 50 | 2.4 | 2.4 | signal |
| 92 | Sinusitis | 58 | 2.4 | 2.4 | signal |
| 93 | Influenza | 63 | 2.4 | 2.4 | signal |
| 94 | Decreased Activity | 6 | 2.4 | 2.4 | no signal |
| 95 | Asthma | 62 | 2.3 | 2.3 | signal |
| 96 | Fluid Retention | 28 | 2.3 | 2.3 | signal |
| 97 | Upper Limb Fracture | 11 | 2.3 | 2.3 | signal |
| 98 | Brain Fog | 8 | 2.3 | 2.3 | signal |
| 99 | Obstructive Airways Disorder | 6 | 2.3 | 2.3 | no signal |
| 100 | Nephropathy | 5 | 2.2 | 2.2 | no signal |
| 101 | Cardiac Failure Congestive | 43 | 2.2 | 2.2 | signal |
| 102 | Pharyngeal Swelling | 5 | 2.2 | 2.2 | no signal |
| 103 | Epistaxis | 39 | 2.2 | 2.2 | signal |
| 104 | Hernia | 10 | 2.2 | 2.2 | signal |
| 105 | Drug Effect Incomplete | 19 | 2.2 | 2.2 | signal |
| 106 | Peripheral Swelling | 79 | 2.2 | 2.2 | signal |
| 107 | Pulmonary Oedema | 23 | 2.2 | 2.2 | signal |
| 108 | Back Pain | 118 | 2.1 | 2.2 | signal |
| 109 | Covid-19 Pneumonia | 6 | 2.1 | 2.1 | no signal |
| 110 | Bladder Disorder | 5 | 2.1 | 2.1 | no signal |
| 111 | Product Physical Issue | 10 | 2.1 | 2.1 | signal |
| 112 | Covid-19 | 88 | 2.1 | 2.1 | signal |
| 113 | Sleep Disorder Due To A General Medical Condition | 8 | 2.1 | 2.1 | no signal |
| 114 | Initial Insomnia | 5 | 2.1 | 2.1 | no signal |
| 115 | Eye Discharge | 5 | 2.1 | 2.1 | no signal |
| 116 | Ear Discomfort | 5 | 2.1 | 2.1 | no signal |
| 117 | Eye Disorder | 16 | 2.1 | 2.1 | signal |
| 118 | Poor Venous Access | 5 | 2.0 | 2.0 | no signal |
| 119 | Scratch | 5 | 2.0 | 2.0 | no signal |
| 120 | Product Odour Abnormal | 5 | 2.0 | 2.0 | no signal |
| 121 | Throat Tightness | 13 | 2.0 | 2.0 | signal |
| 122 | Product Complaint | 12 | 2.0 | 2.0 | signal |
| 123 | Pulmonary Arterial Hypertension | 7 | 2.0 | 2.0 | no signal |
| 124 | Renal Pain | 5 | 2.0 | 2.0 | no signal |
| 125 | Pulmonary Thrombosis | 5 | 1.9 | 1.9 | no signal |
| 126 | Immune System Disorder | 6 | 1.9 | 1.9 | no signal |
| 127 | Eye Pain | 25 | 1.9 | 1.9 | no signal |
| 128 | Limb Discomfort | 14 | 1.9 | 1.9 | no signal |
| 129 | Medication Error | 25 | 1.9 | 1.9 | no signal |
| 130 | Therapy Interrupted | 31 | 1.9 | 1.9 | no signal |
| 131 | Swollen Tongue | 14 | 1.9 | 1.9 | no signal |
| 132 | Sneezing | 10 | 1.9 | 1.9 | no signal |
| 133 | Product Taste Abnormal | 6 | 1.9 | 1.9 | no signal |
| 134 | Therapeutic Response Unexpected | 20 | 1.9 | 1.9 | no signal |
| 135 | Speech Disorder | 23 | 1.8 | 1.8 | no signal |
| 136 | Product Dose Omission Issue | 123 | 1.8 | 1.8 | no signal |
| 137 | Vision Blurred | 59 | 1.8 | 1.8 | no signal |
| 138 | Blood Test Abnormal | 6 | 1.8 | 1.8 | no signal |
| 139 | Muscle Spasms | 77 | 1.8 | 1.8 | no signal |
| 140 | Wrist Fracture | 5 | 1.8 | 1.8 | no signal |
| 141 | Anhedonia | 11 | 1.7 | 1.7 | no signal |
| 142 | Localised Infection | 10 | 1.7 | 1.7 | no signal |
| 143 | Dry Eye | 20 | 1.7 | 1.7 | no signal |
| 144 | Oral Herpes | 8 | 1.7 | 1.7 | no signal |
| 145 | Decreased Immune Responsiveness | 4 | 1.7 | 1.7 | no signal |
| 146 | Cardiac Disorder | 38 | 1.7 | 1.7 | no signal |
| 147 | Glossodynia | 9 | 1.7 | 1.7 | no signal |
| 148 | Spinal Fracture | 8 | 1.7 | 1.7 | no signal |
| 149 | Product Administration Error | 8 | 1.7 | 1.7 | no signal |
| 150 | Lip Swelling | 13 | 1.6 | 1.6 | no signal |
| 151 | Neoplasm Malignant | 26 | 1.6 | 1.6 | no signal |
| 152 | Unevaluable Event | 29 | 1.6 | 1.6 | no signal |
| 153 | Hallucination, Visual | 8 | 1.6 | 1.6 | no signal |
| 154 | Complication Associated With Device | 5 | 1.6 | 1.6 | no signal |
| 155 | Therapy Cessation | 19 | 1.6 | 1.6 | no signal |
| 156 | Device Defective | 6 | 1.6 | 1.6 | no signal |
| 157 | Dementia | 10 | 1.5 | 1.5 | no signal |
| 158 | Intentional Product Misuse | 30 | 1.5 | 1.5 | no signal |
| 159 | Product Prescribing Error | 8 | 1.4 | 1.4 | no signal |
| 160 | Product Dose Omission In Error | 9 | 1.4 | 1.4 | no signal |
| 161 | Spinal Operation | 4 | 1.4 | 1.4 | no signal |
| 162 | Blood Count Abnormal | 5 | 1.4 | 1.4 | no signal |
| 163 | Device Use Error | 11 | 1.4 | 1.4 | no signal |
| 164 | Lymphoma | 5 | 1.4 | 1.4 | no signal |
| 165 | Device Mechanical Issue | 4 | 1.3 | 1.3 | no signal |
| 166 | Metastases To Bone | 5 | 1.3 | 1.3 | no signal |
| 167 | Hunger | 4 | 1.2 | 1.3 | no signal |
| 168 | Procedural Pain | 8 | 1.2 | 1.2 | no signal |
| 169 | Breast Cancer Metastatic | 3 | 1.2 | 1.2 | no signal |
| 170 | Anosmia | 4 | 1.2 | 1.2 | no signal |
| 171 | Dry Skin | 35 | 1.1 | 1.1 | no signal |
| 172 | Drug Dispensing Error | 4 | 1.1 | 1.1 | no signal |
| 173 | Drug Dose Omission By Device | 18 | 1.0 | 1.0 | no signal |
| 174 | Device Use Issue | 4 | 1.0 | 1.0 | no signal |
| 175 | Blood Glucose Decreased | 11 | 1.0 | 1.0 | no signal |
| 176 | Myocardial Infarction | 40 | 1.0 | 1.0 | no signal |
| 177 | Therapeutic Response Shortened | 7 | 0.9 | 0.9 | no signal |
| 178 | Wrong Technique In Device Usage Process | 10 | 0.9 | 0.9 | no signal |
| 179 | Prostatic Specific Antigen Increased | 3 | 0.9 | 0.9 | no signal |
| 180 | Device Leakage | 9 | 0.9 | 0.9 | no signal |
| 181 | Intentional Overdose | 13 | 0.9 | 0.9 | no signal |
| 182 | Incorrect Dose Administered By Device | 5 | 0.8 | 0.8 | no signal |
| 183 | Accidental Exposure To Product | 18 | 0.8 | 0.8 | no signal |
| 184 | Exposure Via Skin Contact | 4 | 0.7 | 0.7 | no signal |
| 185 | Application Site Pruritus | 4 | 0.7 | 0.7 | no signal |
| 186 | Gastric Cancer | 4 | 0.7 | 0.7 | no signal |
| 187 | Breast Cancer Female | 4 | 0.6 | 0.6 | no signal |
| 188 | Product Preparation Error | 3 | 0.6 | 0.6 | no signal |
| 189 | Injection Site Rash | 4 | 0.6 | 0.6 | no signal |
| 190 | Gynaecomastia | 4 | 0.5 | 0.5 | no signal |
| 191 | Device Breakage | 5 | 0.5 | 0.5 | no signal |
| 192 | Device Difficult To Use | 8 | 0.5 | 0.5 | no signal |
| 193 | Application Site Erythema | 3 | 0.5 | 0.5 | no signal |
| 194 | Bladder Cancer | 5 | 0.4 | 0.4 | no signal |